Manager TitleAgeSince
Chief Executive Officer 59 15/09/2024
Director of Finance/CFO 58 24/09/2023
Chief Tech/Sci/R&D Officer 56 -
Director TitleAgeSince
Chairman 74 05/11/2019
Director/Board Member 64 31/10/2019
Chairman 63 03/01/2024
Change 5d. change 1-year change 3-years change Capi.($)
+0.14%+0.14% - - 1.24B
-3.60%-9.61%-9.69%-46.54% 16.19B
+2.32%-13.09%+68.01%+67.37% 2.14B
-2.71%-8.40%-47.87%-76.04% 1.46B
+1.00%-1.82%-21.49%-20.87% 1.08B
+1.69%-4.30%-0.34%-44.02% 830M
+0.02%-8.00%-3.45%-44.92% 782M
-0.77%-2.69%-30.76%-50.14% 561M
-0.17%-9.15%+269.04% - 538M
-8.35%-12.45%-9.36%-35.62% 527M
Average -1.04%-5.67%+23.79%-31.35% 2.68B
Weighted average by Cap. -2.35%-7.87%+0.63%-36.53%
Logo Biotage AB
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Employees
622